The PAMA Final Rule: What You Need to Know and Do NOW to Comply with the New Payment Rules and Protect Your Lab Revenue
Urgent New Lab Compliance Webinar
Purchase this URGENT G2 Intelligence Webinar for analysis on the Final Rule and what it means for laboratories in partnership with the American Clinical Laboratory Association.
Presenters: | Peter M. Kazon Senior Counsel, Alston & Bird Legal Counsel, American Clinical Laboratory Association |
|
Joyce Gresko Senior Associate, Alston & Bird |
||
Paul Sheives Vice President, Reimbursement & Regulatory Policy American Clinical Laboratory Association |
||
Duration: | 90 minutes | |
CEU Credits: | 1.0 | |
Price: | $197.00 |
The highly anticipated PAMA Final Rule is just days away –
and your organization MUST be prepared
The new Protecting Access to Medicare Act of 2014 (PAMA) 216 regulations – now nearing release – completely change the way Centers for Medicare and Medicaid Services determines payment amounts for laboratory services under the Clinical Laboratory Fee Schedule (CLFS).
Under the proposed new rules, labs that have the majority of their Medicare revenues paid under the CLFS or the Physician Fee Schedule (PFS) will be required to report private payor payment rates and corresponding test volumes.
And that’s just the tip of the iceberg. The new PAMA rules also confront affected labs with changes to HCPCS codes, payment rates, and ADLT pricing … along with tough new penalties for failure to comply … a new phase-in schedule … and much more!
Get the Help You Need to Comply with the New PAMA Rules
This special webinar will review and help you:
- Understand the new PAMA 216 rules
- Determine the implications of the first major reform of the Medicare laboratory test rate-setting system in three decades – and what it means for your organization
- Define the process CMS will use going forward and establish prices for laboratory services furnished to Medicare beneficiaries
- Get answers to the myriad of outstanding questions concerning how “applicable laboratories” will be required to report their private payor rates to CMS, including the data collection period
- Gain insight into the host of coding reforms for clinical laboratory tests that are part of this historic overhaul of the fee schedule
- What must now be reported to CMS
- Penalties for non-compliance
- And much more!
Make no mistake – with regulatory clearance imminent, you won’t want to miss this G2 Intelligence webinar in partnership with the American Clinical Laboratory Association to analyze the Final Rule and what it means for laboratories.
About Your Presenters | |
Peter M. Kazon Kazon is a frequent speaker and writer on healthcare issues and sits on the editorial advisory board of Bloomberg BNA’s Medical Devices Law & Industry Report. He has been recognized as one of The Best Lawyers in America.
|
|
Joyce Gresko Gresko draws on her experience prior to becoming an attorney, which includes more than a decade as a public policy advocate and campaign professional and is currently a reading mentor through the Washington D.C. public school program Everybody Wins!
|
|
Paul Sheives Prior to ACLA, he was the Director of Diagnostics and Personalized Medicine Policy at the Biotechnology Industry Organization (BIO). Before BIO, he practiced in two large, international law firms as a legal associate in the areas of FDA and reimbursement law, and prior to that served as a regulatory science advisor. He holds a J.D. from the Georgetown University Law Center, a M.S. in molecular and cellular biology from the University of Texas Southwestern Medical Center at Dallas, and a B.S. in microbiology from the University of Texas at Arlington. |
$0.00